π₯π BizChicken ππ₯
Companies Similar to Gritstone bio, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
INmune Bio, Inc.
INKmune
INmune Bio, Inc. is a clinical-stage immunotherapy company focused on developing drugs to reprogram the patient's innate immune system for the treatment of hematologic malignancies, solid tumors, chronic inflammation, and Alzheimer's disease.
Symbol: INMB
Recent Price: $4.65
Industry: Biotechnology
CEO: Dr. Raymond Joseph Tesi M.D.
Sector: Healthcare
Employees: 11
Address: 225 NE Mizner Boulevard, Boca Raton, FL 33432
Phone: 858 964 3720
Last updated: 2024-12-31
Tourmaline Bio, Inc.
medicines for immune diseases
Tourmaline Bio, Inc. is a clinical biotechnology company focused on developing medicines for patients with life-altering immune diseases, such as Atherosclerotic cardiovascular disease (ASCVD) and Thyroid Eye Disease (TED).
Symbol: TRML
Recent Price: $20.08
Industry: Biotechnology
CEO: Dr. Sandeep C. Kulkarni M.D.
Sector: Healthcare
Employees: 70
Address: 27 West 24th Street, New York, NY 10010
Phone: 646-481-9832
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
Belite Bio, Inc
LBS-008
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.
Symbol: BLTE
Recent Price: $61.97
Industry: Biotechnology
CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.
Sector: Healthcare
Employees: 20
Address: 5820 Oberlin Drive, San Diego, CA 92121
Phone: 858-246-6240
Last updated: 2024-12-31
Biomerica, Inc.
diagnostic and therapeutic products
Biomerica, Inc. is a biomedical technology company that develops, patents, manufactures, and markets diagnostic and therapeutic products for medical conditions and diseases worldwide, focusing on gastrointestinal diseases, food intolerances, and diabetes.
About | About | Contact | Contact | About | News | News | About | About | About | About | About
Symbol: BMRA
Recent Price: $0.31
Industry: Medical - Devices
CEO: Mr. Zackary S. Irani
Sector: Healthcare
Employees: 64
Address: 17571 Von Karman Avenue, Irvine, CA 92614
Phone: 949 645 2111
Last updated: 2024-12-31
BioXcel Therapeutics, Inc.
IGALMI
Bio Xcel Therapeutics, Inc. is a biopharmaceutical company leveraging artificial intelligence for developing transformative medicines in neuroscience and immuno-oncology. It focuses on re-innovating existing drugs with machine learning to identify new therapeutic uses.
Symbol: BTAI
Recent Price: $0.37
Industry: Biotechnology
CEO: Dr. Vimal D. Mehta Ph.D.
Sector: Healthcare
Employees: 74
Address: 555 Long Wharf Drive, New Haven, CT 06511
Phone: 475 238 6837
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Geron Corporation
Imetelstat
Geron Corporation is a late-stage clinical biopharmaceutical company focused on developing and commercializing therapeutics for myeloid hematologic malignancies, notably through their telomerase inhibitor, imetelstat, which is in Phase 3 clinical trials.
Symbol: GERN
Recent Price: $3.40
Industry: Biotechnology
CEO: Dr. John A. Scarlett M.D.
Sector: Healthcare
Employees: 141
Address: 919 East Hillsdale Boulevard, Foster City, CA 94404
Phone: 650 473 7700
Leadership
- John A. Scarlett, M.D., Chairman of the Board, President and Chief Executive Officer
- Melissa A. Kelly Behrs, Executive Vice President, Business Operations and Chief Alliance Officer
- Faye Feller, M.D., Executive Vice President, Chief Medical Officer
- Andrew J. Grethlein, Ph.D., Executive Vice President, Chief Operating Officer
- Edward Koval, Executive Vice President and Chief Business Officer
- Shannon T. Odam, Senior Vice President, Chief People Officer
- Michelle Robertson, Executive Vice President, Chief Financial Officer and Treasurer
- Scott A. Samuels, Esq., Executive Vice President, Chief Legal Officer and Secretary
- Jim Ziegler, Executive Vice President, Chief Commercial Officer
- Gaurav Aggarwal, M.D., Compensation Committee, Strategic Committee (Chair)
- Dawn C. Bir, Nominating and Corporate Governance Committee (Chair), Compensation Committee
- V. Bryan Lawlis, Ph.D., Audit Committee, Nominating and Corporate Governance Committee
- John F. McDonald, Audit Committee, Strategic Committee
- Susan M. Molineaux, Ph.D., Compensation Committee (Chair), Nominating and Corporate Governance Committee
- Elizabeth G. OβFarrell, Lead Director, Audit Committee (Chair), Strategic Committee
- Robert J. Spiegel, M.D., FACP, Compensation Committee, Nominating and Corporate Governance Committee
Last updated: 2024-12-31
Greenwich LifeSciences, Inc.
GP2
Greenwich Life Sciences, Inc. is a clinical stage biopharmaceutical company focusing on developing novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers, with a lead product candidate GP2, which aims to prevent breast cancer recurrences.
Symbol: GLSI
Recent Price: $10.91
Industry: Biotechnology
CEO: Mr. Snehal S. Patel
Sector: Healthcare
Employees: 3
Address: Building 14, Stafford, TX 77477
Phone: 832 819 3232
Last updated: 2024-12-31
Gossamer Bio, Inc.
GB002, GB004, GB5121, GB7208
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics in immunology, inflammation, and oncology. Key products in development include GB002 for pulmonary arterial hypertension, GB004 for inflammatory bowel disease, GB5121 for primary central nervous system lymphoma, and GB7208 for multiple sclerosis.
About | About | Management | Directors | Contact | Locations | Contact | Contact | About | About
Symbol: GOSS
Recent Price: $0.88
Industry: Biotechnology
CEO: Mr. Faheem Hasnain
Sector: Healthcare
Employees: 135
Address: 3013 Science Park Road, San Diego, CA 92121
Phone: 858 684 1300
Leadership
- Faheem Hasnain, Chairman
- Richard Aranda, M.D., Chief Medical Officer
- Jeff Boerneke, General Counsel and Secretary
- Matt Cravets, Senior Vice President, Biometrics
- Bryan Giraudo, Chief Operating Officer & Chief Financial Officer
- Lisa Nolan, Ph.D., Managing Director and President, Gossamer Bio Ireland
- Caryn Peterson, Executive Vice President, Regulatory Affairs
- Bob Smith, Chief Commercial Officer
- Christian Waage, Executive Vice President, Technical Operations & Administration
- Deanna Weber, Senior Vice President, Human Resources
- Russell J. Cox, Director
- Thomas Daniel, Director
- Skye Drynan, Director
- Sandra Milligan, Director
- Steven D. Nathan, Director
- John Quisel, Director
Last updated: 2024-12-31
GRI Bio, Inc.
GRI-0621, GRI-0803, GRI-0124, GRI-0729, ADAIR, ADMIR
GRI Bio, Inc. is a clinical-stage biopharmaceutical company focusing on the treatment of inflammatory, fibrotic, and autoimmune diseases in the United States, with a diverse pipeline including treatments for idiopathic pulmonary fibrosis and systematic lupus erythematosus.
Symbol: GRI
Recent Price: $0.80
Industry: Biotechnology
CEO: Ms. Cristina Gil White
Sector: Healthcare
Employees: 4
Address: 2223 Avenida de la Playa, LA Jolla, CA 92037
Phone: 619 400 1170
Last updated: 2024-12-31
Gritstone bio, Inc.
GRANITE
Gritstone bio, Inc. is a clinical-stage biotechnology company focused on developing immunotherapies for cancer and infectious diseases, with lead products including GRANITE, SLATE, and CORAL.
Symbol: GRTS
Recent Price: $0.03
Industry: Biotechnology
CEO: Dr. Andrew R. Allen BCh, BM, M.D., MA, MRCP, Ph.D.
Sector: Healthcare
Employees: 231
Address: 5959 Horton Street, EmeryVille, CA 94608
Phone: 510 871 6100
Last updated: 2024-12-31
Immunome, Inc.
IMM-ONC-01, IMM-BCP-01
Immunome, Inc. is a biopharmaceutical company focused on developing antibody therapeutics for oncology and infectious diseases, offering innovative solutions such as IMM-ONC-01 for cancer and IMM-BCP-01 for COVID-19 treatment.
Symbol: IMNM
Recent Price: $10.28
Industry: Biotechnology
CEO: Dr. Clay B. Siegall Ph.D.
Sector: Healthcare
Employees: 78
Address: 665 Stockton Drive, Exton, PA 19341
Phone: 610 321 3700
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Instil Bio, Inc.
ITIL-168, ITIL-306
Instil Bio, Inc. is a clinical-stage biopharmaceutical company that develops cell therapies for treating cancer patients, focusing on autologous tumor infiltrating lymphocyte (TIL) treatments.
Symbol: TIL
Recent Price: $18.99
Industry: Biotechnology
CEO: Mr. Bronson Crouch
Sector: Healthcare
Employees: 49
Address: 3963 Maple Avenue, Dallas, TX 75219
Phone: 972 499 3350
Last updated: 2024-12-31
Turnstone Biologics Corp.
TIDAL-01
Turnstone Biologics Corp. is a clinical stage biotechnology company focused on developing medicines for treating and curing patients with solid tumors. Its lead product, TIDAL-01, is in Phase 1 clinical trials for various cancers.
About | About | About | About | About | About | About | About | About | About | About | About
Symbol: TSBX
Recent Price: $0.50
Industry: Biotechnology
CEO: Dr. Sammy J. Farah M.B.A., Ph.D.
Sector: Healthcare
Employees: 82
Address: 9310 Athena Circle, LA Jolla, CA 92037
Phone: 347-897-5988
Last updated: 2024-12-31
Cullinan Oncology, Inc.
CLN-081
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. Their lead candidate, CLN-081, is in a trial for treating non-small cell lung cancer. The company also has several preclinical products targeting various forms of cancer.
Symbol: CGEM
Recent Price: $12.20
Industry: Biotechnology
CEO: Mr. Nadim Ahmed
Sector: Healthcare
Employees: 85
Address: One Main Street, Cambridge, MA 02142
Phone: 617 410 4650
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31
Granite Construction Incorporated
Infrastructure and Construction Services
Granite Construction Incorporated operates as an infrastructure contractor and a construction materials producer in the United States, engaging in the construction and rehabilitation of roads, bridges, and other public infrastructure projects, as well as producing aggregates and asphalt.
About | Leadership | Vision/Values | DEI | About | About | About | Safety | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | Contact | Careers | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | About | About | Careers | Careers | Careers
Symbol: GVA
Recent Price: $88.77
Industry: Engineering & Construction
CEO: Mr. Kyle T. Larkin
Sector: Industrials
Employees: 2100
Address: 585 West Beach Street, Watsonville, CA 95076
Phone: 831 724 1011
Leadership
- Kyle Larkin, President and Chief Executive Officer
- Staci Woolsey, EVP, Chief Financial Officer
- Jim Radich, EVP, Chief Operating Officer
- Craig Hall, SVP, General Counsel, Corporate Compliance Officer, and Secretary
- Tim Gruber, SVP, Human Resources
- Brian Dowd, SVP, Construction
- Brad Estes, SVP, Construction Materials
- Mike Tatusko, SVP, Construction
- Brad Williams, SVP, Construction
- Kim Craig, SVP, Corporate Finance & Treasurer
- Dave Hulverson, SVP, Safety, Health, Environment, & Quality
- Erin Kuhlman, SVP, Chief Marketing & Communications Officer
- Jorge Quezada, Chief Diversity Officer
- Robert Chase, VP, Corporate Development & Strategy
- Tracy Coppinger, VP, Enterprise Excellence
- Jim Grogan, VP, Strategic Initiatives
- Mike McNally, Board Chair
- Louis E. Caldera, Former Secretary of the Army
- Molly C. Campbell, Infrastructure Advisor
- David C. Darnell, Retired Vice Chairman
- Carlos M. Hernandez, Retired CEO
- Alan P. Krusi, Retired President, Strategic Development
- Celeste B. Mastin, President & CEO
- Laura M. Mullen, Retired Partner
Last updated: 2024-12-31